Literature DB >> 31166506

Health technology assessment in Brazil - an international perspective.

Sandra Gonçalves Gomes Lima1, Cláudia de Brito2, Carlos José Coelho de Andrade1.   

Abstract

Given the financial impact of the adoption of new health technologies in health systems, choosing what technology should be introduced and when poses a major challenge for health managers. The health technology assessment (HTA) process should therefore be underpinned by transparent and objective criteria. The objective of this study was to analyze HTA processes in Brazil, overseen by the National Commission for the Incorporation of Health Technology (CONITEC), and to compare these processes with those in countries considered to be at the forefront of this field: Australia, Canada, and the United Kingdom. The following categories were used for the comparative analysis: program structure, definition and selection of topics, evidence review, use of HTA in decision making, program products and dissemination, and transparency. The findings show that there are more similarities than differences between these countries' processes and the CONITEC processes. The main differences identified were: composition of committees, entitlement to appeal, program evaluation, and timeframes for the implementation of recommendations/decisions. Despite making major strides in recent years, Brazil should continue to promote continuous improvement of its HTA process.

Mesh:

Year:  2019        PMID: 31166506     DOI: 10.1590/1413-81232018245.17582017

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

Review 1.  Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.

Authors:  Carlos Barrios; Ruffo Freitas-Junior; Sandro Martins; Jose Bines; Maria Del Pilar Estevez-Diz; Maira Caleffi
Journal:  JCO Glob Oncol       Date:  2021-04

2.  How long does it take to translate research findings into routine healthcare practice?-the case of biological drugs for rheumatoid arthritis in Brazil.

Authors:  Evandro de Oliveira Lupatini; Ivan Ricardo Zimmermann; Jorge Otávio Maia Barreto; Everton Nunes da Silva
Journal:  Ann Transl Med       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.